Evidence map›Paper›PMID 41155399›Full record

ReviewInternational journal of molecular sciences2025

DNA Damage and Repair in Pancreatic Cancer-The Latest Findings.

Małgorzata Kozłowska, Michał Mik, Michał Nowicki, Agnieszka Śliwińska

Abstract readReview
In one paragraph

Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Exploration of targeted anti-tumor therapy · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Małgorzata KozłowskaDepartment of Nucleic Acids Biochemistry, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland.
Michał MikDepartment of General and Colorectal Surgery, Medical University of Lodz, 113 Stefana Zeromskiego St., 90-549 Lodz, Poland.ORCID 0000-0001-6290-1806
Michał NowickiDepartment of General and Colorectal Surgery, Medical University of Lodz, 113 Stefana Zeromskiego St., 90-549 Lodz, Poland.
Agnieszka ŚliwińskaDepartment of Nucleic Acids Biochemistry, Medical University of Lodz, 251 Pomorska St., 92-213 Lodz, Poland.ORCID 0000-0002-6864-0704

Funding

Medical University of Lodz 503/1-159-01/503-11-001 and 503/1-159-01/503-90-438
6 · The paper itself

Abstract

Pancreatic cancer is one of the most common cancers of the gastrointestinal tract, alongside stomach and colon cancers, yet remains among the least studied. Due to its non-specific symptoms, late diagnosis, and limited treatment options, it is associated with a poor prognosis and high mortality. Major risk factors for pancreatic cancer include smoking, alcohol consumption, pancreatitis, obesity, and type 2 diabetes. These environmental factors can damage DNA through various mechanisms and, if not properly repaired, may initiate carcinogenesis. DNA repair is one of the key mechanisms in cancer prevention. It has been suggested that impaired DNA repair may contribute to the development and progression of pancreatic cancer. The aim of this review is to highlight the link between environmental factors, DNA damage and DNA repair in pancreatic cancer. Environmental exposures can trigger a cascade of molecular events, including ROS (reactive oxygen species) overproduction, oxidative stress, insulin resistance, hyperglycemia, and inflammation, that lead to DNA damage. Additionally, up to 25% of patients with PDAC (pancreatic ductal adenocarcinoma) carry mutations in DDR (DNA damage response) genes, and only 5% of all cases are hereditary. Therefore, increased DNA damage combined with disturbances in DDR creates a condition accelerating pancreatic cancer progression. Further research should focus on DDR pathways as potential targets for screening and therapy. Such an approach could significantly improve early diagnosis and treatment outcomes. Moreover, uncovering the mechanisms linking pancreatic cancer aggressiveness with DNA repair deficiencies may lead to the development of specific biomarkers, enabling early detection and potentially improving patient survival.

Indexed as

DNA DamageDNA RepairPancreatic NeoplasmsAnimalsHumansOxidative StressReactive Oxygen SpeciesRisk FactorsReactive Oxygen SpeciesDNA damageDNA repairpancreatic cancer

Identifiers

PMID41155399
PMCPMC12564890

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.